Availability Update for Bicillin® L-A (penicillin G benzathine injectable suspension) and Bicillin® C-R (penicillin G benzathine and penicillin G procaine injectable suspension) Prefilled SyringesRead more about Availability Update for Bicillin® L-A (penicillin G benzathine injectable suspension) and Bicillin® C-R (penicillin G benzathine and penicillin G procaine injectable suspension) Prefilled Syringes
NDC and Packaging Change for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) Multiple-dose VialRead more about NDC and Packaging Change for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) Multiple-dose Vial
NDC and Labeling Change: Rocuronium Bromide NDC Labeling ChangeRead more about NDC and Labeling Change: Rocuronium Bromide NDC Labeling Change
NDC and Labeling Change Linezolid Injection in 0.9% Sodium Chloride 600 mg/300 mL (2 mg/mL) Single-dose ContainerRead more about NDC and Labeling Change Linezolid Injection in 0.9% Sodium Chloride 600 mg/300 mL (2 mg/mL) Single-dose Container
NDC and Labeling Change: Ciprofloxacin in 5% Dextrose Injection, USP 200 mg/100 mL (2 mg/mL) Single-Dose Flexible ContainerRead more about NDC and Labeling Change: Ciprofloxacin in 5% Dextrose Injection, USP 200 mg/100 mL (2 mg/mL) Single-Dose Flexible Container
NDC and Labeling Change for Magnesium Sulfate in Water for Injection 40 g/1000 mL (40 mg/mL) Single-Dose Flexible ContainerRead more about NDC and Labeling Change for Magnesium Sulfate in Water for Injection 40 g/1000 mL (40 mg/mL) Single-Dose Flexible Container
Notification of Emergency Date Extension for Solu-Cortef® (hydrocortisone sodium succinate for injection, USP) 100 mg/2 mL (50 mg/mL) ACT-O-VIAL™ Single Dose VialRead more about Notification of Emergency Date Extension for Solu-Cortef® (hydrocortisone sodium succinate for injection, USP) 100 mg/2 mL (50 mg/mL) ACT-O-VIAL™ Single Dose Vial
Pfizer Hospital Product Return-to-Market: Cleocin Phosphate (clindamycin injection, USP) Vial, Multiple PresentationsRead more about Pfizer Hospital Product Return-to-Market: Cleocin Phosphate (clindamycin injection, USP) Vial, Multiple Presentations
